| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $900.2M | +33.9% |
| Cost of Revenue | $36.1M | -6.9% |
| Gross Profit | $309.6M | +6.8% |
| R&D Expense | $46.4M | -1.8% |
| SG&A Expense | $108.7M | -7.6% |
| Operating Income | $44.6M | +209.9% |
| Pre-tax Income | -$37.4M | +70.1% |
| Income Tax | $4.3M | +271.8% |
| Net Income | -$41.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.6M | -4.9% |
| Accounts Receivable | $97.8M | +77.9% |
| Current Assets | $238.5M | +21.4% |
| Total Assets | $767.7M | -4.4% |
| Current Liabilities | $240.5M | +218.0% |
| Long-term Debt | $344.1M | -34.5% |
| Total Liabilities | $658.9M | -2.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.3M | -7.9% |
| Investing Cash Flow | -$11.2M | +10.1% |
| Financing Cash Flow | -$56.5M | +76.7% |
| +65.9% |
| EPS (Basic) | -$3.14 | +66.8% |
| EPS (Diluted) | -$3.14 | +66.8% |
| Stockholders' Equity |
| $108.8M |
| -12.3% |